Merck & Company, Inc. News Headlines

MRK 
$56.47
*  
0.21
 negative 
0.37%
Get MRK Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Dow Dogs Are Front Of The Pack
4/20/2014 6:33:00 AM - Seeking Alpha

FDA Approves Ragwitek For Short Ragweed Pollen Allergies
4/18/2014 3:49:00 AM - RTT News

Ready For A Rebound? Gilead's $1000 Pill
4/17/2014 7:38:00 AM - Seeking Alpha

Every Portfolio Has Faith
4/16/2014 5:21:00 PM - Seeking Alpha

Cramer's Mad Money - Fear And Loathing On Wall Street (4/15/14)
4/16/2014 6:04:00 AM - Seeking Alpha

Eli Lilly/ Boehringer Drug Under FDA Review - Analyst Blog
4/15/2014 5:25:01 PM - Zacks.com

FDA Nod for Merck's Grastek - Analyst Blog
4/15/2014 5:11:01 PM - Zacks.com

Sector Update: Healthcare Shares Higher Pre-Market; FDA Approves Merck's Grastek Tablet
4/15/2014 8:53:03 AM - MT Newswires

Sector Update: Healthcares
4/15/2014 8:49:56 AM - MT Newswires

Corporate Cash Kings Escape U.S. Taxes
4/15/2014 8:40:00 AM - Fox Business

FDA Approve Merck's Grastek Tablet For Sublingual Use
4/14/2014 6:29:00 PM - RTT News

Hard-to-Cure Patients May Benefit from Merck's HCV Drug - Analyst Blog
4/14/2014 5:10:01 PM - Zacks.com

Markets Falling? Get Your Defense Ready
4/14/2014 2:47:00 PM - Investopedia

Roche's Competitive Advantage
4/14/2014 1:46:56 PM - Trefis

Dow 30 Stock Roundup: Pfizer Drug Trial Dents, P&G Ups Dividend - Analyst Blog
4/11/2014 11:06:01 AM - Zacks.com

3 Biotech Companies That Look To Be Good Buys After A Pullback
4/11/2014 8:32:00 AM - Seeking Alpha

Cramer's Mad Money - The Best Stock Between $10 and $50 (4/10/14)
4/11/2014 6:06:00 AM - Seeking Alpha

Merck Reports Interim Results From Ongoing C-WORTHy Trial - Quick Facts
4/11/2014 1:15:00 AM - RTT News

Bill Nygren Comments on Merck
4/10/2014 6:22:14 PM - GuruFocus

Merck Up on Encouraging HCV Data - Analyst Blog
4/10/2014 4:30:01 PM - Zacks.com

Roche's Competitive Advantage
4/10/2014 4:22:00 PM - Seeking Alpha

Dow Movers: CVX, IBM
4/10/2014 12:27:40 PM - BNK Invest

Noteworthy ETF Inflows: VTV, BRK.B, T, MRK
4/10/2014 11:05:25 AM - BNK Invest

Merck: Hepatitis C Drug Shows 98% Cure Rate in Mid-Stage Trial -- Update
4/10/2014 9:28:00 AM - Dow Jones Business News

Merck: Hepatitis C Drug Shows 98% Cure Rate in Trial
4/10/2014 9:15:00 AM - Dow Jones Business News